Research within Experimental Medicine and Immunotherapeutics (EMIT) Unit is broad in nature. Our main focus is on translating basic scientific findings broadly within the fields of hypertension and cardiovascular medicine into clinical applications (generally drugs).

In addition we are at the forefront of clinical trial research here in Cambridge. We have an excellent track record in publishing in peer-reviewed journals and many of our Consultants hold positions of responsibility within national organisations responsible for clinical guidance. Some information about our activities can be found on the pages within this section but for further information please see the People page detailing specific people’s research interests.